Michelle Lofwall, MD

Departments of Behavioral Science and Psychiatry, University of Kentucky, United States

Titan Pharmaceuticals (Consultant/Advisory Board)

Presentation(s):

• Patterns of Buprenorphine Initiation Treatment for Opioid Use Disorder and Association with Opioid-related Overdose Deaths

  Saturday, August 27, 2022
  8:15 AM – 8:30 AM CEST